Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone added to atypical antipsychotics for negative symptoms of schizophrenia
IRCT2017010431626N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of buspirone in schizophrenia, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
buspirone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT2017010431626N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017010431626N2.